SPC224

Selexipag

  • Status:
    Veitt
  • Application date:
    3.5.2018
  • Application published:
    15.6.2018
  • Grant published:
    15.6.2020
  • Max expiry date:
    18.5.2031
  • Medicine name:
    Uptravi
  • Medicine for children:
    No

Timeline

Today
3.5.2018Application
15.6.2018Publication
15.6.2020Registration
18.5.2031Expires

Marketing license

  • IS authorization number:
    EU/1/15/1083/001-010
  • Date:
    26.5.2016
  • Foreign authorization number:
    EU/1/15/1083
  • Date:
    12.5.2016

Owner

  • Name:
    Nippon Shinyaku Co., Ltd.
  • Address:
    14, Kisshoin Nishinosho Monguchicho Minami-ku, Kyoto-shi Kyoto JP

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Upload documents